338 related articles for article (PubMed ID: 22003387)
1. Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1.
Wozniak MA; Frost AL; Preston CM; Itzhaki RF
PLoS One; 2011; 6(10):e25152. PubMed ID: 22003387
[TBL] [Abstract][Full Text] [Related]
2. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1.
Wozniak MA; Frost AL; Itzhaki RF
Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β and p-Tau Anti-Threat Response to Herpes Simplex Virus 1 Infection in Primary Adult Murine Hippocampal Neurons.
Powell-Doherty RD; Abbott ARN; Nelson LA; Bertke AS
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075924
[TBL] [Abstract][Full Text] [Related]
4. Anti-HSV1 activity of brown algal polysaccharides and possible relevance to the treatment of Alzheimer's disease.
Wozniak M; Bell T; Dénes Á; Falshaw R; Itzhaki R
Int J Biol Macromol; 2015 Mar; 74():530-40. PubMed ID: 25583021
[TBL] [Abstract][Full Text] [Related]
5. Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial.
Devanand DP; Andrews H; Kreisl WC; Razlighi Q; Gershon A; Stern Y; Mintz A; Wisniewski T; Acosta E; Pollina J; Katsikoumbas M; Bell KL; Pelton GH; Deliyannides D; Prasad KM; Huey ED
BMJ Open; 2020 Feb; 10(2):e032112. PubMed ID: 32034019
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin reduces β amyloid and abnormal tau formation caused by herpes simplex virus type 1.
Wozniak MA; Itzhaki RF
J Neuroimmunol; 2013 Apr; 257(1-2):7-12. PubMed ID: 23385080
[TBL] [Abstract][Full Text] [Related]
7. Herpes and Alzheimer's Disease: Subversion in the Central Nervous System and How It Might Be Halted.
Itzhaki RF
J Alzheimers Dis; 2016 Oct; 54(4):1273-1281. PubMed ID: 27497484
[TBL] [Abstract][Full Text] [Related]
8. Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease.
Devanand DP
Curr Neurol Neurosci Rep; 2018 Jul; 18(9):55. PubMed ID: 30008124
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus.
Itzhaki RF
Front Aging Neurosci; 2014; 6():202. PubMed ID: 25157230
[TBL] [Abstract][Full Text] [Related]
10. β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1.
Bourgade K; Garneau H; Giroux G; Le Page AY; Bocti C; Dupuis G; Frost EH; Fülöp T
Biogerontology; 2015 Feb; 16(1):85-98. PubMed ID: 25376108
[TBL] [Abstract][Full Text] [Related]
11. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1.
Wozniak MA; Frost AL; Itzhaki RF
J Alzheimers Dis; 2009; 16(2):341-50. PubMed ID: 19221424
[TBL] [Abstract][Full Text] [Related]
13. Potential Involvement of Varicella Zoster Virus in Alzheimer's Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1.
Cairns DM; Itzhaki RF; Kaplan DL
J Alzheimers Dis; 2022; 88(3):1189-1200. PubMed ID: 35754275
[TBL] [Abstract][Full Text] [Related]
14. Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer's Disease.
Itzhaki RF
Front Aging Neurosci; 2018; 10():324. PubMed ID: 30405395
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's Gone Viral: Could Herpes Simplex Virus Type-1 Be Stealing Your Memories?
Khokale R; Kang A; Buchanan-Peart KR; Nelson ML; Awolumate OJ; Cancarevic I
Cureus; 2020 Nov; 12(11):e11726. PubMed ID: 33403161
[TBL] [Abstract][Full Text] [Related]
16. In vitro antiviral activity of dermaseptins against herpes simplex virus type 1.
Belaid A; Aouni M; Khelifa R; Trabelsi A; Jemmali M; Hani K
J Med Virol; 2002 Feb; 66(2):229-34. PubMed ID: 11782932
[TBL] [Abstract][Full Text] [Related]
17. Activity of penciclovir in antiviral assays against herpes simplex virus.
Bacon TH; Howard BA; Spender LC; Boyd MR
J Antimicrob Chemother; 1996 Feb; 37(2):303-13. PubMed ID: 8707740
[TBL] [Abstract][Full Text] [Related]
18. Antiviral Properties of the LSD1 Inhibitor SP-2509.
Harancher MR; Packard JE; Cowan SP; DeLuca NA; Dembowski JA
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699090
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase 14 regulates HSV-1 infection in neuroblastoma cells.
Llorente P; Mejías V; Sastre I; Recuero M; Aldudo J; Bullido MJ
Antiviral Res; 2021 Aug; 192():105116. PubMed ID: 34107282
[TBL] [Abstract][Full Text] [Related]
20. No evidence of aberrant amyloid β and phosphorylated tau expression in herpes simplex virus-infected neurons of the trigeminal ganglia and brain.
Tran DN; Bakx ATCM; van Dis V; Aronica E; Verdijk RM; Ouwendijk WJD
Brain Pathol; 2022 Jul; 32(4):e13044. PubMed ID: 34913212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
